Valion Bio, Inc. short interest in 2026

In 2026, Valion Bio, Inc.'s disclosed short interest ran from 3.95% of shares outstanding on 30 Jan 2026 to 26.18% on 31 Jul 2026, a change of +22.23 percentage points. The year's high was 26.18% on 31 Jul 2026 and its low 1.93% on 27 Feb 2026, averaging 6.70% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.72 days on 27 Feb 2026. Full history: Valion Bio, Inc..

Cite this page

Plain

Short position data for Valion Bio, Inc. short interest in 2026: FINRA, compiled by howshorted.com, settlement date 31 Jul 2026. https://howshorted.com/us/company/vbio/2026/

Wikipedia

<ref>{{cite web |title=Valion Bio, Inc. short interest in 2026 short position data |url=https://howshorted.com/us/company/vbio/2026/ |website=HowShorted |publisher=howshorted.com (data: FINRA) |date=2026-07-31 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-valion-bio-inc-short-interest-in-2026-2026-07-31,
  title        = {Valion Bio, Inc. short interest in 2026 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/us/company/vbio/2026/}},
  note         = {Data: FINRA, settlement date 31 Jul 2026; accessed 2026-10-13},
  year         = {2026}
}

By year: 2022 · 2023 · 2024 · 2025 · 2026

2026 in figures

Start of year: 3.95% (30 Jan 2026)
End of year: 26.18% (31 Jul 2026)
Change: +22.23 pp
High: 26.18% (31 Jul 2026)
Low: 1.93% (27 Feb 2026)
Average: 6.70%
Highest days to cover: 1.72 (27 Feb 2026)
SEC filings marked: 5

Every report in 2026

Valion Bio, Inc. short interest in 2026
Settlement	Short interest	Days to cover	Filings since previous
30 Jan 2026	3.95%	1.00
13 Feb 2026	2.66%	1.00
27 Feb 2026	1.93%	1.72
31 Mar 2026	3.24%	1.00	results (8-K), 10-K filed
15 Apr 2026	2.22%	1.00
31 Jul 2026	26.18%	1.00	10-Q filed, results (8-K)

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.